All news from Anaesthesiology

Novel genes of type 2 diabetic islets were identified

A combined study by Prof. Michele Solimena have demonstrated a novel cluster of dysregulated genes in the pancreatic islets of patients with type 2 diabetes. Type 2 diabetes, which affects more than 500 million people worldwide, results from the inability of beta cells in the pancreatic islets to provide the body with enough insulin to maintain blood glucose levels. These findings are now published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

Alternative Therapies to Combat Antibiotic Resistance

The mild infections may make a large contribution to antibiotic use, and could have a big impact on resistance evolution. A new study published in the journal PLOS Biology suggests that development of alternative therapies for mild infections could help slow the development and spread of antibiotic resistance, thereby preserving the drugs' effectiveness for use in severe infections.

FDA Approved: New Dermatological Drugs Introduced In 2017

New drugs translate to the advancement of health care in the United States, and each year the CDER approves a wide range of new drugs and biological products. In 2015 and 2016, the FDA approved 45 and 29 new therapies, respectively. This year, the FDA is on pace to approve about 38 new medications. Additions to the drug market this year cover a variety of diseases and ailments, providing prescribers with more options and the ability to optimize drug therapy.